We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

Back to rankings

71 hedge funds and large institutions have $76.9M invested in Immune Design Corp. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

11% less funds holding

Funds holding: 80 → 71 (-9)

29% less capital invested

Capital invested by funds: $108M → $76.9M (-$31.5M)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
71
Holders Change
-9
Holders Change %
-11.25%
% of All Funds
1.62%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
27
Reduced
22
Closed
17
Calls
$327K
Puts
–
Net Calls
+$327K
Net Calls Change
-$366K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$1.88M
2
PCM
Portolan Capital Management
Massachusetts
+$1.06M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$807K
4
Renaissance Technologies
Renaissance Technologies
New York
+$553K
5
BCM
Bridgeway Capital Management
Texas
+$525K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$8.24M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.7M
3
BCPEM
Bain Capital Public Equity Management
Massachusetts
-$306K
4
EIM
Essex Investment Management
Massachusetts
-$192K
5
TAM
Tiverton Asset Management
Delaware
-$176K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
51
Algert Global
California
$52K +$10.9K +2,900 +24%
Barclays
52
Barclays
United Kingdom
$49K +$43.3K +11,531 +467%
Walleye Trading
53
Walleye Trading
New York
$47K +$10.2K +2,710 +25%
QSS
54
Quantitative Systematic Strategies
Florida
$47K +$51.5K +13,716 New
VOYA Investment Management
55
VOYA Investment Management
Georgia
$46K – – –
AIM
56
Alambic Investment Management
California
$45K +$48.8K +13,000 New
TRCT
57
Tower Research Capital (TRC)
New York
$43K +$47.1K +12,548 New
State of Wisconsin Investment Board
58
State of Wisconsin Investment Board
Wisconsin
$41K – – –
UBS Group
59
UBS Group
Switzerland
$39K +$19.7K +5,248 +90%
Millennium Management
60
Millennium Management
New York
$37K -$20.6K -5,500 -34%
Invesco
61
Invesco
Georgia
$36K -$5.19K -1,383 -12%
Marshall Wace
62
Marshall Wace
United Kingdom
$36K +$38.7K +10,298 New
Citigroup
63
Citigroup
New York
$32K +$10.3K +2,744 +42%
Legal & General Group
64
Legal & General Group
United Kingdom
$20K – – –
AIP
65
Ameritas Investment Partners
Nebraska
$10K – – –
FWM
66
Focused Wealth Management
New York
$6K -$17.2K -4,580 -72%
IP
67
Intellectus Partners
California
$3K – – –
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$2.04K -$11 -3 -0.5%
AG
69
Advisor Group
Arizona
$2K +$1.88K +500 New
Bank of Montreal
70
Bank of Montreal
Ontario, Canada
$1K -$26 -7 -3%
EIM
71
Essex Investment Management
Massachusetts
– -$192K -42,179 Closed
TAM
72
Tiverton Asset Management
Delaware
– -$176K -38,675 Closed
Balyasny Asset Management
73
Balyasny Asset Management
Illinois
– -$112K -24,712 Closed
PCM
74
Prelude Capital Management
New York
– -$92K -20,302 Closed
MWNA
75
Marshall Wace North America
New York
– -$82K -17,959 Closed
1 2
3
4

IMDZ Hedge Fund Activity: Q3 2018 in Review

71 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q3 2018, worth a combined $76.9M — down 29% from $108M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of IMDZ and 8 opened new positions — a net loss of 9 holders — while 22 trimmed existing stakes and 27 added.

The largest buyer was BVF Inc, adding an estimated $1.88M. The largest seller was EcoR1 Capital, cutting an estimated $8.24M.

  • 71 institutional investors held Immune Design Corp. (IMDZ) as of Q3 2018, down from 80 in Q2 2018.
  • Funds reported $76.9M of Immune Design Corp. stock for Q3 2018, down 29% quarter-over-quarter.
  • 8 funds opened new Immune Design Corp. positions in Q3 2018 and 17 closed out, a net change of -9 holders.
  • The largest Immune Design Corp. buyer in Q3 2018 was BVF Inc, an estimated $1.88M added.
  • The largest Immune Design Corp. seller in Q3 2018 was EcoR1 Capital, an estimated $8.24M sold.

Based on aggregated 13F filings for Q3 2018.